Inflammation and depression: Is there a causal connection with dementia?;Zánět a deprese: Kauzální spojení s demencí?

Psychiatrie

Volumn 10, Issue 3, 2006, Pages 172-178

  Leonard, Brian E ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Hypercortisolaemia; Inflammation; Kynurenic acid; Neurodegeneration; Proinflammatory cytokines; Prostaglandin E2; Quinolinic acid

Indexed keywords

3 HYDROXYKYNURENINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; QUINOLINIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; INFLAMMATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; SYNAPTIC TRANSMISSION;

EID: 33750060720     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Altman J. Autoradiographic and histological studies of postnatal neurogenesis. 4. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in infant rats, with special reference to postnatal neurogenesis in some brain regions. J Comp Neurol 1966;431-474.
2. Altman J. Autoradiographic and histological studies of postnatal neurogenesis. 4. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 1969;137:433-457.
3. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965;124:319-335.
4. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localised alterations in pre- and post-synaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121-133.
5. Ashtari M, Greenwald BS, Kramer-Ginsberg E, Hu J, WU H, Patel M, Aupperle P, Pollack S. Hippocampal/amygdale volumes in geriatric depression. Psychol Med 1999;29:629-638.
6. Axelson DS, Doraiswamy PM, McDonald WM. Hypercortisolemia and hippocampal changes in depression. Psychiat Res 1993;47:163-173.
7. Bell-MacGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF 3rd, Becker JT. Brain morphometric abnormalities in geriatric depression: long-term neuro-biological effects of illness duration. Am J Psychiat 2002;159:1424-1427.
8. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. Serotonin SHT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiat 1997;171:444-448.
9. Bowley MP, Drevets WC, Ongur D, Price JL. Glial changes in the amygdale and entorhinal cortex in mood disorders. Soc Neurosci Abs 2000;26:876.10.
10. Bremner JD, Narayan M, Anderson ER, Stab LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiat 2000;157:115-118.
11. Burt DB, Zember MJ, Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern and specificity. Psychol Bull 1995;117:285-305.
12. Calabrese JR, Skwerer AG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE. Depression, immunocompetence and prostaglandins of the E series. Psychiat Res 1986;17:41-47.
13. Campbell IK, Roberts LJ, Wicks IP. Molecular targets in immune mediated diseases: the case of TNF and rheumatoid arthritis. Immunol Cell Biol 2003;81:354-366.
14. Carlin JM, Borden EC, Sondel PM, Byrne GI. Biologic response modifier induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol 1987;139:2414-2418.
15. Chiarugi A, Calvani M, Meli E, Tragiai E, Moroni F. Synthesis and release of neurotoxic kynurenine metabolites by human derived macrophages. J Neuroimmunol 2001;120:190-198.
16. Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, Figier GS, Webb MC, Spritzer CE, Djang WT. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992;42:527-536.
17. Cohen-Cory S. The developing synapse: construction and modification of synaptic structures and circuits. Science 2002;298:770-776.
18. Cotter DR, Pariante CE, Everall IP. Gial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001;55:585-595.
19. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new approach to shock, inflammation and ischaemia/reperfusion injury. Pharmacol Revs 2001;53:135-159.
20. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827.
21. Duman RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiat 1998;44:324-335.
22. Fujioka T, Fujioka A, Duman RS. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci 2004;24:319-328.
23. Gallant JE. Initial therapy of HIV infection. J Clin Virol 2002;25:317-333.
24. Gilbertson HW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neurosci. 2002;5:1242-1247.
25. Grant RS, Kapoor V. Murine glial cells regenerate NAD, after peroxide-induced depletion, using nicotinic acid, nicotinamide or quinolinic acid as substrates. J Neurochem 1998;70:1759-1763.
26. Geerlings MI, Schoevers RA, Beckman AT, Jonker C, Deeg DJ, Schmand B, Ader HJ, Bouter LM, Van Tilburg W. Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community based studies in the Netherlands. Br J Psychiat 2000;176:568-575.
27. Greenwald BS, Kramer-Ginsberg E, Bogerts B, Ashtari M, Aupperle P, Wu H, Allen L, Zeman D, Patel M. Quantitative magnetic resonance imaging findings in geriatric depression. Possible link between late-onset depression and Alzheimer's disease. Psychol Med 1997;27:421-431.
28. Griffin DE, Wesselingh SL, McArthur JC. Elevated CNS prostaglandins in human immunodeficiency virus associated dementia. Ann Neurol 1994;35:592-597.
29. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ. The kynurenine pathway metabolism in human astrocytes: pathway for neuroprotection. J Neurochem 2001;78;842-853.
30. Guillemin GJ, Smythe G, Takikawa O, Brew BJ. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons. Glia 2005;49:15-23.
31. Harvey BH. Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness? Hum Psychopharmacol 1996;11:309-319.
32. Hayaishi O. Biochemical and medical aspects of tryptophan metabolism. Amsterdam: Elsevier/North Holland Biomedical Press 1980.
33. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Brain 1993;16:1425-1450.
34. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP. Human microglia convert 1-tryptophan into the neuroxin quinolinic acid. Biochem J 1996;320(part2):595-597.
35. Hua JY, Smith SJ. Neural activity and the dynamics of central nervous system development. Nature Neurosci 2004;7:446-451.
36. Ikeda-Matsuo Y, Ikegaya Y, Matsuki N, Uematsu S, Akira S, Sasaki Y. Microglia specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced PGE2 production. J Neurochem 2005;94.1546-1558.
37. Irwin M, Smith TL, Gillin JC. Low natural killer cell cytotoxicity in major depression. Life Sci 1997;41:2127-2133.
38. Kanne SM, Balota DA, Storandt M, McKeel DW Jr, Morris JC. Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurology 1998;50:979-985.
39. Kaplan MS, Bell DH. Neuronal proliferation in the 9 month old rodent-radioautographic study of granule cells in the hippocampus. Exp Brain Res 1983;52:1-5.
40. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiat 1990;51:3-11.
41. Katz LC, Shatz CJ. Synaptic activity and the construction of cortical circuits. Science 1996;274:1133-1138.
42. Kim JP, Choi DW. Quinolinate neurotoxicity in cortical cell cultura. Neuroscience 1987;23:423-432.
43. Klein J. Functions and pathophysiological roles of phospholipase D in the brain. J Neurochem 2005;94:1473-1487.
44. Krishnan KR, McDonald WM, Escalona PR, Doraiswamy PM, Na C, Hussain MM, Figiel GS, Boyko OB, Ellinwood EM, Nemeroff CB. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiat 1992;49:553-557.
45. Kronfol Z, House JD. Depression, HPA activity and lymphocyte function. Acta Psychiat Scand 1987;80:142-147.
46. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, Thomas LB, O'Brien TF, Kusakabe M, Steindler DA. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 1999;156:333-344.
47. Leonard BE. Brain cytokines and the psychopathology of depression. In: Antidepressants (Ed. Leonard, BE) Birkhauser Verlag, Basel 2001;109-120.
48. Leonard BE, Myint A-M. Changes in the immune system in depression and dementia: causal or co-incidental effects? Dialogues Clin Neurosci 2006;8:(in press).
49. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic interventions. J Pharmacol Exper Therapeut 2003;304:1-7.
50. Lyketsos CG, Olin J. Depression in Alzheimer's disease: overview and treatment. Biol Psychiat 2002;52:243-252.
51. MacQueen GM, Campbell S, McEwen B, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. Course of illness, hippocampal volume and hippocampal function in major depression. Proc Natl Acad Sci USA 2003;100:1387-1392.
52. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1R antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9:853-858.
53. Malberg JE, Eisch AJ, Nessler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110.
54. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nature Med 2001;7:541-547.
55. Marshall PS. Allergy and depression: a neurochemical threshold model of the relation between the illnesses. Psychol Bull 1993;113:23-43.
56. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Ach Intern Med 1996;156:223-228.
57. McEwen BS. Possible mechanisms for atrophied human hippocampus. Mol Psychiat 1997;2:255-262.
58. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the sustantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291.
59. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 1999;20:469-473.
60. Meyers CA, Valentine AD. Neurologic and psychiatric adverse effects of immunological therapy. CNS Drugs 1995;3:56-68.
61. Minden SL, Schiffer RB. Affective disorder in multiple sclerosis. Gen Hosp Psychiat 1990;9:426-434.
62. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology: nomenclature in nitric oxide research. Pharmacol Revs 1997;49:137-142.
63. Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of the Alzheimer type: a prospective study. Arch Neurol 2004;61:1290-1293.
64. Myint A-M, Kim Y-K. Cytokine-serotonin interactions through indoleamine 2,3-dioxygenase: a neurodegenerative hypothesis of depression. Med Hypoth 2003;61:519-525.
65. Myint A-M, Leonard BE, Steinbusch HW, Kim Y-K. Th1, Th2 and Th3 cytokine alterations in major depression. J Affect Dis 2005;88:169-173.
66. Myint A-M, Kim Y-K, Vrkerk R. Tryptophan metabolites in major depression: evidence of an inbalance in neurodegeneration and neuroprotection. 2005;(submitted).
67. Myint A-M, O'Mahony SM, Kubera M. Role of paroxetine in interferon-alpha infuced immune and behavioural changes in male Wister rats. J Psychopharmacol 2006;(in press).
68. Musso T, Gusella GL, Brooks A, Longo DL, Varesio L. Interleukin-4 inhibits indoleamine 2,3 dioxygenase expression in human monocytes. Blood 1994;83:1408-1411.
69. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
70. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and TrkB mRNA in rat brain by chronic electroshock seizures and antidepressant drug treatments. J Neurosci 1995;15:7549-7547.
71. Nibuya M, Takahashi M, Russell DS, Duman RS. Chronic stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999;267:81-84.
72. O'Mahony SM, Myint A-M, Steinbusch H, Leonard BE. Efavirenz induces depressive like behaviour, increased stress response and changes in the immune response in rats. Neuroimmunomod 2005;12:293-298.
73. Onger D, Drevets WC, Price JL. Glia reduction in subgenual pre-frontal cortex in mood disorders. Proc Nat Acad Sci USA 1998;95:13290-13295.
74. Papassotiropoulos A, Bagli M, Jessen F, Rao ML, Schwab SG, Heun R. Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E. Dement Geriatr Cogn Disord 1999;10:258-261.
75. Perkins MN, Stone TW. An iontophorectic investigation of the actions of convulsant kynurenines and their interaction with endogenous quinolinic acid. Brain Res 1982;247:184-187.
76. Posener JA, Wang L, Price JL, Gado MH, Province MA, Williams GH, Schatzberg AF. High dimensional mapping of the hippocampus in depression. Am J Psychiat 2003;160:83-89.
77. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BC, Stockmeier CA. Morphometric evidence for neuronal and glia pre-frontal cell pathology in major depression. Biol Psychiat 1999;45:1085-1098.
78. Saarelainen T. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurose. 2003;23:349-357.
79. Sairanen M, Lucas G, Emfors P, Castren M, Castren E. BDNF and antidepressant drugs have different but co-ordinated effects on neuronal turnover, proliferation and survival in the adult dentate gyrus. J Neurosci 2005;25:1089-1094.
80. Santarelli L. Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 2003;301:805-809.
81. Schrott LM, Crnic LS. Anxiety behavior, exploratory behavior and activity in NZB × and NZB F1 hybrid mice: role of genotype and autoimmune disease progression. Brain Behav Immun 1996;10:260-274.
82. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration, but not age, predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-5043.
83. Sheline YL. Brain structural changes associated with depression. In: Depression and brain dysfunction. (Eds. Gilliam, FG, Kanner, AM, Sheline, YL) Taylor and Francis, London, 2006: 85-104.
84. Sheline YL, Wang P, Gado M, Csernansky JG, Vannier MW. Hippocampus atrophy in recurrent major depression. Proc Natl Acad Sci 1999;93:3908-3913.
85. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K. Indicators of immune activation in major depression. Psychiat Res 1996;64:162-167.
86. Smith R. The macrophage theory of depression. Med Hypoth 1991;35:298-306,
87. Smith MA, Makino S, Kvetnansky R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995;771:234-239.
88. Song C, Dinan T, Leonard BE. Changes in immunoglobulins, complement and acute phase proteins in depressed patients and normal controls. J Affect Dis 1994;30:283-288.
89. Song H, Poo M. The cell biology of neuronal navigation. Nat Cell Biol 2001;3:E81-88.
90. Steffens DC, Krishnan, KR. Structural Neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiat 1998;43:705-712.
91. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC. A twin study of late-onset depression and apolipoprotein E4 as risk factors for Alzheimer's disease. Biol Psychiat 1997;41:851-856.
92. Stern Y, McDermott MP, Albert S, Palumbo D, Seines OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS. Factors associated with incident human immunodeficiency virus dementia. Arch Neurol 2001;58:473-479.
93. Stone TW, Darlington LG. Endogenous kynureninsas as targets for drug discovery and development. National Rev Drug Discovery 2002;1:609-620.
94. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Dis 1998;49:211-219.
95. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvansen GS, Roses AD. Apolipoprotein E: high avidity binding to beta amyloid and increased frequency of type 4 allele in late-onset Familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
96. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270:593-598.
97. Torpe L, Groulx B. Depressive syndromes in dementia. Canad J Neurol Sci 2001;28: S83-S95.
98. Vaidya VA, Siuciak JA, Du, F, Duman, RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999;89:157-166.
99. Visser PJ, Verhey FR, Ponds RW, Kester A, Jolles J. Distinction between preclinical Alzheimer's disease and depression. J Amer Geriatric Soc 2000;48:479-484.
100. Vythilingham M. Childhood trauma associated with smaller hippocampal volume in women with major depression. Amer J Psychiat. 2002;159:2072-2080.
101. Wichers MC, Koek GH, Robaeys, G, Verkerk R, Sharpe S, Maes M. IDO and interferon alpha induced depressive symptoms: a shift in hypothesis from tryptophan depletion. Mol Psychiat 2005;10:538-544.
102. Young SN, Smith PE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacol. (Berl.) 1985;87:173-177.